{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:19:13Z","timestamp":1794777553376,"version":"4.9.1"},"reference-count":83,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51873168"],"award-info":[{"award-number":["51873168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Parkinson\u2019s disease (PD), a prevalent neurodegenerative disorder characterized by dopaminergic neuron degeneration and \u03b1-synuclein accumulation, has been increasingly associated with coagulation dysfunction. This review synthesizes emerging evidence linking dysregulated coagulation to PD pathophysiology. We examine the alterations in coagulation parameters, including elevated fibrinogen levels, impaired fibrinolysis, and platelet dysfunction, which collectively contribute to a hypercoagulable state in PD patients. Epidemiological studies have revealed a higher incidence of thrombotic events, such as deep vein thrombosis (DVT) and stroke, among PD patients, suggesting significant comorbidity between PD and coagulation disorders. This review explores the potential pathophysiological mechanisms underlying this association, focusing on the roles of inflammation and oxidative stress. Additionally, we discuss the limitations of current research and propose future directions. This comprehensive analysis underscores the importance of understanding the coagulation\u2013neurodegeneration axis in PD, which may lead to novel diagnostic and therapeutic strategies for this debilitating condition.<\/jats:p>","DOI":"10.3390\/cells13221874","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T06:10:48Z","timestamp":1731478248000},"page":"1874","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dysregulated Coagulation in Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"13","author":[{"given":"Xinqing","family":"Wang","sequence":"first","affiliation":[{"name":"School of Public Health, Hengyang Medical School, University of South China, Hengyang 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Li","sequence":"additional","affiliation":[{"name":"School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Xiao","sequence":"additional","affiliation":[{"name":"School of Public Health, Hengyang Medical School, University of South China, Hengyang 421001, China"},{"name":"State Key Laboratory of Chemo\/Biosensing and Chemometrics, Hunan University, Changsha 410082, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9758-9870","authenticated-orcid":false,"given":"Kai","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China"},{"name":"Hubei Key Laboratory of Nanomedicine for Neurodegenerative Diseases, School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taolei","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China"},{"name":"Hubei Key Laboratory of Nanomedicine for Neurodegenerative Diseases, School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China"},{"name":"State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41583-021-00542-9","article-title":"Motor and non-motor circuit disturbances in early Parkinson disease: Which happens first?","volume":"23","author":"Blesa","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: From structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson\u2019s disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","article-title":"Therapeutic strategies for thrombosis: New targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00441-021-03471-2","article-title":"Endothelial cells and coagulation","volume":"387","author":"Neubauer","year":"2022","journal-title":"Cell Tissue Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jth.12045","article-title":"Platelet-based coagulation: Different populations, different functions","volume":"11","author":"Heemskerk","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100733","DOI":"10.1016\/j.blre.2020.100733","article-title":"Interplay between platelets and coagulation","volume":"46","author":"Sang","year":"2021","journal-title":"Blood Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/bja\/88.6.848","article-title":"Thrombin generation and its inhibition: A review of the scientific basis and mechanism of action of anticoagulant therapies","volume":"88","author":"Walker","year":"2002","journal-title":"Br. J. Anaesth."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1111\/jth.12935","article-title":"Basic mechanisms and regulation of fibrinolysis","volume":"13","author":"Longstaff","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Adams, B., Nunes, J.M., Page, M.J., Roberts, T., Carr, J., Nell, T.A., Kell, D.B., and Pretorius, E. (2019). Parkinson\u2019s Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens. Front. Aging Neurosci., 11.","DOI":"10.3389\/fnagi.2019.00210"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"214.e1","DOI":"10.1016\/j.neurobiolaging.2015.10.026","article-title":"Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson\u2019s disease","volume":"38","author":"Infante","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1021\/acs.jproteome.0c01002","article-title":"Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in alpha-Synuclein-Based Mouse Models of Parkinson\u2019s Disease","volume":"20","author":"Ma","year":"2021","journal-title":"J. Proteome Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000260070","article-title":"Association of fibrinogen with Parkinson disease in elderly Japanese-American men: A prospective study","volume":"34","author":"Wong","year":"2010","journal-title":"Neuroepidemiology"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lu, W., Wan, X., Liu, B., Rong, X., Zhu, L., Li, P., Li, J., Wang, L., Cui, L., and Wang, X. (2014). Specific changes of serum proteins in Parkinson\u2019s disease patients. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095684"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2217\/bmm.09.4","article-title":"Lymphocyte proteomics of Parkinson\u2019s disease patients reveals cytoskeletal protein dysregulation and oxidative stress","volume":"3","author":"Mila","year":"2009","journal-title":"Biomark. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/acschemneuro.2c00019","article-title":"Fibrinogen and Complement Factor H Are Promising CSF Protein Biomarkers for Parkinson\u2019s Disease with Cognitive Impairment horizontal line A Proteomics-ELISA-Based Study","volume":"13","author":"Naskar","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Pretorius, E., Page, M.J., Mbotwe, S., and Kell, D.B. (2018). Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson\u2019s disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192121"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","article-title":"Striatal blood-brain barrier permeability in Parkinson\u2019s disease","volume":"35","author":"Gray","year":"2015","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1179\/1743132812Y.0000000063","article-title":"Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson\u2019s disease subjects","volume":"34","author":"Maarouf","year":"2012","journal-title":"Neurol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2009.01.058","article-title":"Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases","volume":"1265","author":"Yin","year":"2009","journal-title":"Brain Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2006-9309","article-title":"Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders","volume":"9","author":"Abdi","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/187152508784871981","article-title":"Alterations of fibrinogen structure in human disease","volume":"6","author":"Hoffman","year":"2008","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zago, E., Dal Molin, A., Dimitri, G.M., Xumerle, L., Pirazzini, C., Bacalini, M.G., Maturo, M.G., Azevedo, T., Spasov, S., and Gomez-Garre, P. (2022). Early downregulation of hsa-miR-144-3p in serum from drug-naive Parkinson\u2019s disease patients. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-05227-6"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Cervilla-Martinez, J.F., Rodriguez-Gotor, J.J., Wypijewski, K.J., Fontan-Lozano, A., Wang, T., Santamaria, E., Fuller, W., and Mejias, R. (2022). Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.20944\/preprints202210.0306.v1"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Sharma, A., Muller, J., Schuetze, K., Rolfes, V., Bissinger, R., Rosero, N., Ahmad, A., Franklin, B.S., Zur, B., and Frohlich, H. (2021). Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson\u2019s Disease. Biology, 10.","DOI":"10.3390\/biology10080716"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1182\/blood.V78.12.3114.3114","article-title":"Basic and clinical aspects of fibrinolysis and thrombolysis","volume":"78","author":"Collen","year":"1991","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1749-6632.2001.tb03511.x","article-title":"Elements of the fibrinolytic system","volume":"936","author":"Lijnen","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1538-7836.2007.02464.x","article-title":"Fibrinolysis, inflammation, and regulation of the plasminogen activating system","volume":"5","author":"Medcalf","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"24862","DOI":"10.1074\/jbc.M112.348128","article-title":"Proteolytic cleavage of extracellular alpha-synuclein by plasmin: Implications for Parkinson disease","volume":"287","author":"Kim","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1160\/TH08-04-0269","article-title":"Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins","volume":"100","author":"Kruithof","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"109602","DOI":"10.1016\/j.mehy.2020.109602","article-title":"Synergy between plasminogen activator inhibitor-1, alpha-synuclein, and neuroinflammation in Parkinson\u2019s disease","volume":"138","author":"Reuland","year":"2020","journal-title":"Med. Hypotheses"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1007\/s11064-022-03673-2","article-title":"Exogenous Tetranectin Alleviates Pre-formed-fibrils-induced Synucleinopathies in SH-SY5Y Cells by Activating the Plasminogen Activation System","volume":"47","author":"Lin","year":"2022","journal-title":"Neurochem. Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Chou, S.C., Tai, C.H., and Tseng, S.H. (2022). Platelet abnormalities in patients with Parkinson\u2019s disease undergoing preoperative evaluation for deep brain stimulation. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-18992-1"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archinte.163.6.735","article-title":"Thrombocytopenia associated with levodopa treatment","volume":"163","author":"Giner","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14802\/jmd.13005","article-title":"Thrombocytopenia associated with levodopa treatment","volume":"6","author":"Lee","year":"2013","journal-title":"J. Mov. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bcmd.2018.09.001","article-title":"Ultrastructural changes in peripheral blood leukocytes in alpha-synuclein knockout mice","volume":"73","author":"Tashkandi","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"986254","DOI":"10.1155\/2013\/986254","article-title":"Assessment of platelet indices in patients with neurodegenerative diseases: Mean platelet volume was increased in patients with Parkinson\u2019s disease","volume":"2013","author":"Kocer","year":"2013","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0022-510X(94)90056-6","article-title":"Platelet morphology in Parkinson\u2019s disease: An electron microscopic study","volume":"122","author":"Factor","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.thromres.2010.01.009","article-title":"Mice with deleted multimerin 1 and alpha-synuclein genes have impaired platelet adhesion and impaired thrombus formation that is corrected by multimerin 1","volume":"125","author":"Reheman","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Acquasaliente, L., Pontarollo, G., Radu, C.M., Peterle, D., Artusi, I., Pagotto, A., Uliana, F., Negro, A., Simioni, P., and De Filippis, V. (2022). Exogenous human alpha-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting alpha-thrombin-induced platelet activation. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-12886-y"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1161\/01.STR.22.12.1607","article-title":"Platelet aggregation in patients with Parkinson\u2019s disease","volume":"22","author":"Sharma","year":"1991","journal-title":"Stroke"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09537100902721746","article-title":"Inhibition of platelet aggregation by 1-methyl-4-phenyl pyridinium ion (MPP+) through ATP depletion: Evidence for the reduced platelet activities in Parkinson\u2019s disease","volume":"20","author":"Lim","year":"2009","journal-title":"Platelets"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00415-019-09348-3","article-title":"Does the MDS-UPDRS provide the precision to assess progression in early Parkinson\u2019s disease? Learnings from the Parkinson\u2019s progression marker initiative cohort","volume":"266","author":"Regnault","year":"2019","journal-title":"J. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1542\/peds.111.1.e89","article-title":"Classification and definition of disorders causing hypertonia in childhood","volume":"111","author":"Sanger","year":"2003","journal-title":"Pediatrics"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1039\/D0LC00287A","article-title":"Effects of altered blood flow induced by the muscle pump on thrombosis in a microfluidic venous valve model","volume":"20","author":"Hu","year":"2020","journal-title":"Lab. Chip"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1080\/01616412.2023.2257441","article-title":"The incidence of deep venous thrombosis in Parkinson\u2019s disease","volume":"45","author":"Afsin","year":"2023","journal-title":"Neurol. Res."},{"key":"ref_48","first-page":"338","article-title":"Doppler ultrasonographic examination of the leg veins of patients with Parkinson disease","volume":"24","author":"Burbridge","year":"1999","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jocn.2021.07.007","article-title":"Deep venous thrombosis in patients with neurological diseases: A multicenter, prospective study","volume":"91","author":"Nakajima","year":"2021","journal-title":"J. Clin. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Yamane, K., Kimura, F., Unoda, K., Hosokawa, T., Hirose, T., Tani, H., Doi, Y., Ishida, S., Nakajima, H., and Hanafusa, T. (2013). Postural abnormality as a risk marker for leg deep venous thrombosis in Parkinson\u2019s disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066984"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000280821","article-title":"Asymptomatic deep venous thrombosis after deep brain stimulation for Parkinson disease","volume":"88","author":"Zibetti","year":"2010","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2147\/RMHP.S469725","article-title":"A Silent Threat: Deep Vein Thrombosis in Early-Stage Parkinson\u2019s Disease","volume":"17","author":"Li","year":"2024","journal-title":"Risk Manag. Healthc. Policy"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.870090316","article-title":"Pulmonary embolism: An under-recognized yet frequent cause of death in parkinsonism","volume":"9","author":"Mosewich","year":"1994","journal-title":"Mov. Disord."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e222018","DOI":"10.1136\/bcr-2017-222018","article-title":"Massive pulmonary embolism presenting initially as acute psychosis","volume":"12","author":"Co","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_55","first-page":"487","article-title":"Parkinson\u2019s disease with recurrent pulmonary embolism","volume":"63","author":"Hung","year":"2000","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.parkreldis.2009.06.005","article-title":"Risk of stroke in patients with idiopathic Parkinson disease","volume":"16","author":"Becker","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.parkreldis.2012.07.003","article-title":"Parkinson disease: Associated disorders in the Norwegian population based incident ParkWest study","volume":"19","author":"Skeie","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/01.STR.21.10.1395","article-title":"Stroke and its modification in Parkinson\u2019s disease","volume":"21","author":"Struck","year":"1990","journal-title":"Stroke"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0303-8467(76)80005-4","article-title":"Arteriosclerosis, heredity, and some previous infections in the etiology of Parkinson\u2019s disease. A case-control study","volume":"79","author":"Marttila","year":"1976","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1111\/ene.15838","article-title":"Risk of myocardial infarction in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"30","author":"Nabizadeh","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1111\/hae.13235","article-title":"Subthalamic nucleus deep brain stimulation for Parkinson\u2019s disease in a patient with severe haemophilia A","volume":"23","author":"Boehlen","year":"2017","journal-title":"Haemophilia"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/S0140-6736(22)01691-9","article-title":"Subacute parkinsonism due to systemic lupus erythematosus and catastrophic antiphospholipid syndrome","volume":"400","author":"Hebbink","year":"2022","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jns.2007.10.003","article-title":"Parkinsonism in a patient with antiphospholipid syndrome--case report and literature review","volume":"267","author":"Huang","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/mds.20842","article-title":"Atypical movement disorders in antiphospholipid syndrome","volume":"21","author":"Martino","year":"2006","journal-title":"Mov. Disord."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1353-8020(00)00025-0","article-title":"Antiphospholipid syndrome and dystonia-parkinsonism. A case report","volume":"7","author":"Milanov","year":"2001","journal-title":"Park. Relat. Disord."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2169\/internalmedicine.9880-17","article-title":"Reversible Parkinsonism and Multiple Cerebral Infarctions after Pulmonary Endarterectomy in a Patient with Antiphospholipid Syndrome","volume":"57","author":"Okano","year":"2018","journal-title":"Intern. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.2169\/internalmedicine.31.1298","article-title":"Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson\u2019s disease","volume":"31","author":"Yamawaki","year":"1992","journal-title":"Intern. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebrian","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2021.12.003","article-title":"Environmental factors in Parkinson\u2019s disease: New insights into the molecular mechanisms","volume":"356","author":"Yuan","year":"2022","journal-title":"Toxicol. Lett."},{"key":"ref_70","first-page":"713517","article-title":"Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2019s disease","volume":"2011","author":"Litteljohn","year":"2010","journal-title":"Park. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/01.ATV.20.10.2322","article-title":"Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression","volume":"20","author":"Lindmark","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"103931","DOI":"10.1016\/j.mcn.2024.103931","article-title":"Systemic inflammation activates coagulation and immune cell infiltration pathways in brains with propagating alpha-synuclein fibril aggregates","volume":"129","author":"Laursen","year":"2024","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","article-title":"Oxidative Stress in Neurodegenerative Diseases","volume":"53","author":"Niedzielska","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/ATVBAHA.114.303785","article-title":"Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction","volume":"34","author":"Becatti","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/hh0801.089861","article-title":"Nitric oxide insufficiency, platelet activation, and arterial thrombosis","volume":"88","author":"Loscalzo","year":"2001","journal-title":"Circ. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/CIRCULATIONAHA.112.000966","article-title":"Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis","volume":"127","author":"Dayal","year":"2013","journal-title":"Circulation"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/mds.20117","article-title":"Cigarette smoking in Parkinson\u2019s disease: Influence on disease progression","volume":"19","author":"Alves","year":"2004","journal-title":"Mov. Disord."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"107022","DOI":"10.1016\/j.parkreldis.2024.107022","article-title":"Smoking exposure and Parkinson\u2019s disease: A UK Brain Bank pathology-validated case-control study","volume":"125","author":"Pecoraro","year":"2024","journal-title":"Park. Relat. Disord."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-3940(91)90804-3","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: Partial protection against striato-nigral dopamine depletion in C57BL\/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment","volume":"127","author":"Shahi","year":"1991","journal-title":"Neurosci. Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-1781(87)90079-5","article-title":"Platelet monoamine oxidase: Low activity in cigarette smokers","volume":"20","author":"Norman","year":"1987","journal-title":"Psychiatry Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/0024-3205(81)90706-2","article-title":"Low platelet monoamine oxidase activity in cigarette smokers","volume":"29","author":"Oreland","year":"1981","journal-title":"Life Sci."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/22\/1874\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:31:13Z","timestamp":1760113873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/22\/1874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":83,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["cells13221874"],"URL":"https:\/\/doi.org\/10.3390\/cells13221874","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]}}}